At a glance
ClinicalIndex Comparison RecordN/ACompleted· 22 enrolled
Drug / intervention
ARGOS-SC suprachoroidal pressure sensordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Follow-up of the First in Man, Prospective, Open-label, Single Arm, Multicenter Clinical Investigation to Assess the Long-term Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glaucoma Underwent Non-penetrating Glaucoma Surgery (Follow-up Month 12 - Month 36)
In Brief
A clinical study evaluating ARGOS-SC suprachoroidal pressure sensor for Glaucoma and Open Angle Glaucoma. Completed, enrolled 22 participants across 5 sites in 2 countries.
Detailed Summary
The purpose of this study is to evaluate the long-term safety and performance of the ARGOS-SC system.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Open Angle Glaucoma
CountriesGermany, Switzerland
CollaboratorsCRO Dr. med Kottmann GmbH & Co. KG
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartFeb 2020
First PostedFeb 2021
Primary CompletionMar 2023
TodayJul 2026
First PostedFeb 26, 2021
Enrollment StartFeb 20, 2020
Primary CompletionMar 2, 2023
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 5.4 years ago
Interventions
ARGOS-SC suprachoroidal pressure sensordevice
The ARGOS-SC pressure sensor was additionally implanted during routine local intraocular pressure lowering procedures in patients with glaucoma undergoing non-penetrating glaucoma surgery in the earlier ARGOS-SC01 study.